pharma news today glp-1 obesity drugs today biotech Therapies Reshape Future of Healthcare Eli Lilly obesity pill Foundayo

FDA staff recommends against adding any of these 7 peptides to the 503A Bulks List: BPC-157 (free base/acetate) KPV (free base/acetate) TB-500 (free base/acetate) MOTS-c (free base/acetate) Emideltide/DSIP (free base/acetate) Epitalon (free base/acetate) Semax (free base/acetate) What it means: The 503A Bulks List allows compounding pharmacies to create customized versions for patients with a prescription

An additional potential mechanism involves the interference with the regulation of renal blood flow

Progressive decrease of melatonin production over consecutive days of simulated night work

Among them, GLP-1 and GIP (gastric inhibitory polypeptide) are known as incretins, gut-derived hormones that enhance glucose-dependent insulin secretion, playing a pivotal role in maintaining glucose homeostasis and serve as important therapeutic targets for type 2 diabetes and obesity